MedInsights Unleashed

MedInsights Unleashed

Download on the App Store

MedInsights Unleashed episodes

  • Immunotherapy in Colorectal Cancer: A Game Changer?

    Episode Summary:

    This is the second episode in our series on colorectal cancer. In this episode of MedInsights Unleashed, we sit down with Prof. Paulo Hoff, MD, PhD, from the University of São Paulo, Brazil, to discuss the latest developments in colorectal cancer treatment. With cases increasing, especially among younger adults, the conversation underscores the importance of early screening and detection. Prof. Hoff explains how tumor location—right vs. left side—affects treatment strategies, the role of genetic markers in guiding decisions, and how immunotherapy is shaping new treatment options. Listeners will gain a clearer understanding of molecular profiling, personalized care, and what these advancements mean for patients facing colorectal cancer.

    32 min
  • Cracked! Exposing the Truth About Osteoporosis in Men

    Osteoporosis is often viewed as a women’s disease, but in this episode of MedInsights Unleashed, Dr. Tom Forfa, MBBS, reveals why men are also at serious risk. A retired physician and osteoporosis educator from Queensland, Australia, Dr. Forfa shares his personal journey, from multiple fractures to a delayed diagnosis, highlighting the need for early screening and awareness.

    This episode uncovers misconceptions, risk factors, and treatment options, including an unexpected dietary ally—prunes. Recent research suggests that daily prune consumption may help maintain bone density and support fracture healing, making it a promising nonpharmacologic approach to osteoporosis prevention.

    👉 If you think osteoporosis only affects women, think again.

    50 min
  • Comprehensive Colorectal Cancer Care: From Screening to Survival with Prof. Paulo Hoff MD. PhD.

    In this latest episode of MedInsights Unleashed, we are delighted to welcome Dr. Paulo Hoff, MD, PhD, Professor of Clinical Oncology at the Department of Radiology and Oncology, University of São Paulo. Dr. Hoff discusses the rising incidence of colorectal cancer in younger populations, highlighting key risk factors including poor diet, sedentary lifestyle, and obesity. He emphasizes the critical importance of beginning regular screening at age 45.

    The discussion covers the complete treatment journey, from initial diagnosis through staging—which determines both local and distant tumor spread—to help create optimal treatment plans. Dr. Hoff explains that some patients may require temporary or permanent colostomy procedures.

    A significant focus is placed on the emerging total neoadjuvant treatment (TNT) approach, which administers all chemotherapy and radiation before surgery to improve outcomes. The episode concludes by emphasizing the value of collaborative care, bringing together different oncology specialists for comprehensive treatment

    32 min
  • Breaking the Silence: Triple-Negative Breast Cancer Unveiled

    In this MedInsights Unleashed episode, Dr. Christine Simmons, MD, Associate Professor in the Faculty of Medicine at UBC (University of British Columbia) and specialist in breast cancer and sarcoma, provides an in-depth exploration of the breast cancer journey, focusing on diagnosis, staging, and cutting-edge treatments for triple-negative breast cancer. She discusses the critical role of subtype differentiation and personalized care, with a particular emphasis on advancements in managing triple-negative breast cancer. Highlighting the transformative potential of immunotherapy, Dr. Simmons likens it to removing the "invisibility cloak" from cancer cells, enabling the immune system to target them effectively. Balancing innovation with caution, she also addresses the possible side effects of these treatments, offering a nuanced perspective on this rapidly evolving field. This episode is an essential resource for understanding the challenges and breakthroughs in breast cancer care.

    58 min
  • The Importance of Breast Cancer Screening
    In this podcast episode, medical oncologist, Christine Simmons discusses the importance of breast cancer screening and the impact of the pandemic on the process. She highlights the drop in global participation in mammogram screenings, increasing instances of advanced disease diagnoses, and the resultant increase in aggressive treatments.
    44 min
  • Breaking Financial Barriers: Bringing Hope to Cancer Patients in Armenia Through Clinical Trials

    Elen Baloyan, MD, Oncology Fellow at Yeolyan Hematology and Oncology Center in Yerevan, Armenia, shares her insightful journey in this MedInsights Unleashed podcast episode. She addresses the financial toxicity affecting both doctors and patients in Armenia, which often leads to treatment refusals and late diagnoses due to high costs. Despite government efforts to support cancer care, the financial burden remains significant. Elen discusses the future of clinical trial development and the hope it brings to patients through the Immune Oncology Research Institute in Armenia. Elen's diverse roles, from medical practice to managing editor at OncoDaily, highlight pressing issues and her commitment to finding solutions. This episode emphasizes the need for greater financial support and education in the medical field.

    41 min
  • Precision Medicine: Tailoring Treatments One Gene at a Time

    In this episode of MedInsights Unleashed, Dr. Oliver Bathe MD FRCSC, Professor of Surgery and Oncology University, CEO Qualisure Diagnostics Inc. discusses his journey from surgical oncology to pioneering precision cancer care. He delves into the role of machine learning in analyzing vast genomic databases to personalize treatment and improve patient outcomes. Dr. Bathe shares personal insights, emphasizing the importance of tailoring cancer therapies to individual patients. The podcast explores the creation and application of diagnostic tests, like those for thyroid cancer, which offer more targeted treatment options and hope for patients confronting a complex healthcare landscape.

     Qualisure Diagnostics Inc contact information:

    Oliver F. Bathe, MD - CEO & Founder

    3655 36th Street NW Calgary, Alberta T2L 1Y8

    p: +1 403.614.7124

    e:  [email protected] | www.qualisuredx.com

    33 min
  • A Deeper Dive into Recurrent Head and Neck Cancer

    In this MedInsights Unleashed episode, Dr. Ari Rosenberg from University Chicago Medical Center, delves into the complexities and advancements in the treatment of head and neck cancers. Despite the recurrence and resistance these cancers often develop, immunotherapy has marked a significant breakthrough, especially in releasing the immune system's brakes. Although its introduction in early-stage cancer remains elusive, ongoing trials indicate potential when combined with chemotherapy pre-treatment. Dr. Rosenberg highlights innovative therapies, including targeting HPV-specific cancer proteins and antibody drug conjugates, which hold promise in enhancing treatment efficacy. These cutting-edge strategies aim to outmaneuver resistant cancer cells, providing hope for improved survival rates.

    33 min
  • Unlocking the Mysteries of Liver Cancer in France: A Chat with Professor Philippe Merle MD Ph.D

    In this episode Professor Philippe Merle explains the interplay between chronic liver conditions and the development of HCC. The conversation highlights the significance of early diagnosis and consistent patient monitoring to catch the disease in its nascent stages. Professor Merle also discusses the evolving landscape of HCC treatments, including innovative therapies and the benefits of a multidisciplinary medical team in managing complex cases.

    30 min
  • Insights into Clinical Trial Design, Adverse Events, Sexual Disfunction from Renal Cell Cancer and Treatments - Discussion with Prof Michael Staehler

    In this episode of Med Insights Unleashed, hosts Zee and John welcome Michael Staehler MD Ph.D, Professor of Urology at the University of Munich and Head the Interdisciplinary Center for Renal Tumors at Ludwig-Maximilian University, Munich. to discuss renal cell carcinoma. He explains how patient selection and managing side effects, including sexual dysfunction, play critical roles in effective cancer treatment. The conversation also delves into the balance between drug efficacy and patient experience, highlighting the importance of patient communication and personalized care in clinical practice.

    39 min

About MedInsights Unleashed

From the publisher's feed

The MedInsights Unleashed Podcast aims to break down complex clinical data to provide insights from cutting-edge developments into tangible benefits for physicians, patients, and caregivers around the globe.